🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 12 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/03/2025 | 308,09 | 315,53 | 305,33 | 308,59 | -0,46% | 3,31% | 649.300 |
| 03/03/2025 | 316,46 | 320,76 | 307,92 | 310,03 | -3,13% | 4,06% | 640.500 |
| 28/02/2025 | 324,06 | 324,06 | 313,66 | 320,05 | -1,10% | 3,21% | 657.500 |
| 27/02/2025 | 318,80 | 326,74 | 315,07 | 323,62 | +1,48% | 3,66% | 997.200 |
| 26/02/2025 | 343,53 | 344,81 | 307,38 | 318,89 | -10,80% | 10,90% | 1.699.400 |
| 25/02/2025 | 362,42 | 364,98 | 351,08 | 357,50 | -0,20% | 3,84% | 591.200 |
| 24/02/2025 | 361,35 | 365,22 | 358,17 | 358,21 | -0,80% | 1,95% | 874.900 |
| 21/02/2025 | 366,60 | 369,00 | 355,85 | 361,10 | -1,70% | 3,59% | 407.200 |
| 20/02/2025 | 377,29 | 378,52 | 362,50 | 367,36 | -3,52% | 4,25% | 633.000 |
| 19/02/2025 | 373,15 | 383,51 | 371,94 | 380,78 | +2,13% | 3,10% | 564.800 |
| 18/02/2025 | 370,00 | 374,35 | 366,00 | 372,83 | +0,61% | 2,26% | 431.900 |
| 14/02/2025 | 370,93 | 370,93 | 364,62 | 370,58 | +0,04% | 1,70% | 209.300 |
| 13/02/2025 | 369,00 | 372,69 | 365,00 | 370,44 | -0,08% | 2,08% | 302.100 |
| 12/02/2025 | 352,61 | 370,89 | 350,24 | 370,74 | +4,93% | 5,86% | 626.600 |
| 11/02/2025 | 348,05 | 363,00 | 346,49 | 353,31 | +2,22% | 4,74% | 508.300 |
| 10/02/2025 | 351,24 | 351,24 | 345,22 | 345,64 | -0,60% | 1,71% | 347.800 |
| 07/02/2025 | 355,76 | 357,00 | 344,39 | 347,71 | -1,71% | 3,54% | 291.400 |
| 06/02/2025 | 355,93 | 356,57 | 351,29 | 353,75 | -0,12% | 1,48% | 466.400 |
| 05/02/2025 | 348,21 | 358,87 | 348,21 | 354,18 | +0,21% | 3,06% | 386.200 |
| 04/02/2025 | 353,10 | 355,78 | 348,52 | 353,43 | -0,32% | 2,06% | 312.100 |
| 03/02/2025 | 348,17 | 358,63 | 344,36 | 354,58 | +0,97% | 4,10% | 369.000 |
| 31/01/2025 | 355,18 | 357,31 | 350,02 | 351,17 | -0,32% | 2,05% | 414.600 |
| 30/01/2025 | 370,00 | 370,40 | 349,07 | 352,30 | -5,49% | 5,76% | 500.900 |
| 29/01/2025 | 373,00 | 378,52 | 370,20 | 372,75 | +0,51% | 2,23% | 169.600 |
| 28/01/2025 | 370,99 | 382,61 | 368,02 | 370,85 | +0,35% | 3,93% | 320.200 |
| 27/01/2025 | 369,82 | 375,35 | 368,52 | 369,56 | -0,34% | 1,85% | 246.100 |
| 24/01/2025 | 372,73 | 375,61 | 365,88 | 370,83 | -0,29% | 2,61% | 198.600 |
| 23/01/2025 | 372,55 | 374,15 | 367,02 | 371,89 | +0,16% | 1,91% | 243.300 |
| 22/01/2025 | 371,37 | 373,88 | 366,20 | 371,28 | +0,90% | 2,07% | 318.200 |
| 21/01/2025 | 361,00 | 369,85 | 360,46 | 367,97 | +2,52% | 2,60% | 655.400 |